Risk and Clinical Consequences of Low Count Monoclonal B-cell Lymphocytosis (LC MBL)
Risk and Clinical Consequences of Low Count Monoclonal B-cell Lymphocytosis (LC MBL)
Not yet recruiting · NCT06416267 · Registry updated 2024-05-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Risk and Clinical Consequences of Low Count Monoclonal B-cell Lymphocytosis (LC MBL) | Alzheimer disease, B-cell chronic lymphocytic leukemia, Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Infections, Leukemia, B-Cell, Neoplasms by Histologic Type, Parkinson disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, basal ganglia disorder, brain disorder, cancer, cardiovascular disorder, central nervous system disorder, cognitive disorder, dementia, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, movement disorder, neoplasm, nervous system disorder, neurodegenerative disease, parkinsonian disorder, psychiatric disorder, synucleinopathy, tauopathy | Not yet recruiting | Not stated | 2024-05-16 | NCT06416267 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bnai Zion Medical Center | 13 |
| Clalit Health Services, Haifa and West Galilee | 1 |
| University of Haifa | 27 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||